Inventor · disambiguated record
Madan Katragadda
Also filed as: KATRAGADDA MADAN
10 granted patents·20 pending applications·92 citations·filing 2006–2025
85Inventor score
Top patents by PatentIndex Score
30 records- 0196US7888323B2Potent compstatin analogsUNIV PENNSYLVANIA·Filed 2006·Granted Feb 15, 2011·65 cites·25 claims
- 0292US9169307B2Potent compstatin analogsLAMBRIS JOHN D·Filed 2011·Granted Oct 27, 2015·22 cites·19 claims
- 0391US12486326B2Anti-TCR antibody molecules and uses thereofMARENGO THERAPEUTICS INC·Filed 2023·Granted Dec 2, 2025·1 cites·10 claims
- 0483US12384842B2Antibody molecules that bind to NKP30 and uses thereofMARENGO THERAPEUTICS INC·Filed 2021·Granted Aug 12, 2025·1 cites·23 claims
- 0575US11613581B2Antibodies and antibody-drug conjugates specific for CD123 and uses thereofPFIZER·Filed 2018·Granted Mar 28, 2023·2 cites·26 claims
- 0674US2025154270A1Antibodies and antibody-drug conjugates specific for cd123 and uses thereofPFIZER·Filed 2024·Application pending·0 cites
- 0773US11434292B2Antibodies specific for CD3 and uses thereofPFIZER·Filed 2019·Granted Sep 6, 2022·1 cites·20 claims
- 0870US2023227552A1Anti-tcr antibody molecules and uses thereofMARENGO THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0968US12269896B2Antibodies specific for GUCY2c and uses thereofPFIZER·Filed 2022·Granted Apr 8, 2025·0 cites·12 claims
- 1066US2024409636A1Multifunctional molecules binding to tcr and uses thereofMARENGO THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1166US2023357417A1Antibodies and antibody-drug conjugates specific for cd123 and uses thereofPFIZER·Filed 2023·Application pending·0 cites
- 1264US2025011459A1Multifunctional molecules comprising g6b binder and/or cd34 binder and uses thereofMARENGO THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1363US2025333500A1Multifunctional molecules that bind to t cell related cancer cells and uses thereofMARENGO THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1463US2024002543A1Multifunctional molecules that bind to calreticulin and uses thereofMARENGO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1563US2023348593A1Antibody molecules that bind to nkp30 and uses thereofMARENGO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1661US12358982B2Multifunctional molecules that bind to T cell related cancer cells and uses thereofMARENGO THERAPEUTICS INC·Filed 2021·Granted Jul 15, 2025·0 cites·23 claims
- 1761US2024400990A1Immune cell populations and uses thereofMARENGO THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1860US2019016758A1Potent Compstatin AnalogsUNIV PENNSYLVANIA·Filed 2018·Application pending·0 cites
- 1958US2023333112A1Methods of detecting trbc1 or trbc2MARENGO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2058US2017305971A1Potent compstatin analogsUNIV PENNSYLVANIA·Filed 2017·Application pending·0 cites
- 2157US11525010B2Antibodies specific for GUCY2c and uses thereofPFIZER·Filed 2019·Granted Dec 13, 2022·0 cites·24 claims
- 2257US2025099579A1Multispecific molecules binding to tcr and uses thereofMARENGO THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2357US2023102344A1Multifunctional molecules that bind to cd33 and uses thereofMARENGO THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2455US2023357395A1Multifunctional molecules that bind to t cell related cancer cells and uses thereofMARENGO THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2554US2016096866A1Potent compstatin analogsUNIV PENNSYLVANIA·Filed 2015·Application pending·0 cites
- 2653US11364303B2Cysteine engineered antibody drug conjugatesPFIZER·Filed 2018·Granted Jun 21, 2022·0 cites·6 claims
- 2752US2021380670A1Multifunctional molecules that bind to calreticulin and uses thereofMARENGO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2851US2021380691A1Multifunctional molecules that bind to t cells and uses thereof to treat autoimmune disordersMARENGO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2946US2025297007A1Multifunctional molecules binding to tcr and uses thereofMARENGO THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 3033US2013142792A1RAGE Fusion Protein Compositions And Methods Of UseWEBSTER JEFFREY C·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Madan Katragadda files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →